dab peroxidase substrate kit (Vector Laboratories)
Vector Laboratories is a verified supplier 
Vector Laboratories manufactures this product 
96
Structured Review
Vector Laboratories
dab peroxidase substrate kit
Dab Peroxidase Substrate Kit, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 12394 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/3+3+diaminobenzidine+dab+substrate+kit/DAB+Peroxidase+(HRP)+Substrate+Kit+(with+Nickel)%2C+3%2C3%E2%80%99-diaminobenzidine/pmc13059316-74-43-47
Average 96 stars, based on 12394 article reviews
Dab Peroxidase Substrate Kit, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 12394 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/3+3+diaminobenzidine+dab+substrate+kit/DAB+Peroxidase+(HRP)+Substrate+Kit+(with+Nickel)%2C+3%2C3%E2%80%99-diaminobenzidine/pmc13059316-74-43-47
Average 96 stars, based on 12394 article reviews
dab peroxidase substrate kit - by Bioz Stars,
2026-09
96/100 stars
Images
Related Articles
Incubation:Article Title: MYLK4 promotes colorectal cancer progression by regulating lipid metabolism reprogramming via targeting ferroptosis. Article Snippet: Following a wash with PBS, the slides were blocked with 10% BSA (#V900933, Sigma-Aldrich) at 37◦C for 1 h. The sections were then incubated overnight at 4◦C with the specified primary antibodies. .. The following day, the sections underwent successive washes with PBS buffer for 5 min before being incubated with enhanced enzyme-labeled goat anti-rabbit IgG at 37◦C for 1 h. IHC staining was performed using a Article Title: A Wireless Endovascular Deep Brain Stimulator for Parkinson's Disease Article Snippet: Deep brain stimulation (DBS) is a well-established treatment for Parkinson’s disease (PD), yet its traditional approaches involving craniotomy and battery implants are highly invasive and pose significant clinical risks.. To overcome these limitations, we developed a novel wireless endovascular DBS system (WE-DBS) that enables minimally invasive, battery-free stimulation via a vascularly implanted stent electrode and ultrasound-powered wireless energy transmission.. In an MPTP-induced PD mouse model, WE-DBS treatment significantly enhanced motor performance and protected dopaminergic neurons in the substantia nigra. Article Title: Unlocking dexmedetomidine's therapeutic potential in multiple sclerosis: Dual modulation of PI3K/Akt/BDNF and TLR4/NF-κB pathways in EAE rats. Article Snippet: Multiple sclerosis (MS) is an enduring autoimmune and neurodegenerative disease affecting the central nervous system with inflammation, demyelination, and axonal degeneration that progresses to neurological impairment.. Despite available treatments, their limited efficacy, inability to promote remyelination, and associated adverse reactions highlight the need for unconventional therapies.. This study investigated the therapeutic potential of dexmedetomidine (DEX), a selective α2-adrenergic receptor (α2AR) agonist, in a rat model of MS triggered by experimental autoimmune encephalomyelitis (EAE). Article Title: MYLK4 promotes colorectal cancer progression by regulating lipid metabolism reprogramming via targeting ferroptosis Article Snippet: Following a wash with PBS, the slides were blocked with 10% BSA (#V900933, Sigma-Aldrich) at 37°C for 1 h. The sections were then incubated overnight at 4°C with the specified primary antibodies. .. The following day, the sections underwent successive washes with PBS buffer for 5 min before being incubated with enhanced enzyme-labeled goat anti-rabbit IgG at 37°C for 1 h. IHC staining was performed using a Immunohistochemistry:Article Title: MYLK4 promotes colorectal cancer progression by regulating lipid metabolism reprogramming via targeting ferroptosis. Article Snippet: Following a wash with PBS, the slides were blocked with 10% BSA (#V900933, Sigma-Aldrich) at 37◦C for 1 h. The sections were then incubated overnight at 4◦C with the specified primary antibodies. .. The following day, the sections underwent successive washes with PBS buffer for 5 min before being incubated with enhanced enzyme-labeled goat anti-rabbit IgG at 37◦C for 1 h. IHC staining was performed using a Article Title: MYLK4 promotes colorectal cancer progression by regulating lipid metabolism reprogramming via targeting ferroptosis Article Snippet: Following a wash with PBS, the slides were blocked with 10% BSA (#V900933, Sigma-Aldrich) at 37°C for 1 h. The sections were then incubated overnight at 4°C with the specified primary antibodies. .. The following day, the sections underwent successive washes with PBS buffer for 5 min before being incubated with enhanced enzyme-labeled goat anti-rabbit IgG at 37°C for 1 h. IHC staining was performed using a Staining:Article Title: MYLK4 promotes colorectal cancer progression by regulating lipid metabolism reprogramming via targeting ferroptosis. Article Snippet: Following a wash with PBS, the slides were blocked with 10% BSA (#V900933, Sigma-Aldrich) at 37◦C for 1 h. The sections were then incubated overnight at 4◦C with the specified primary antibodies. .. The following day, the sections underwent successive washes with PBS buffer for 5 min before being incubated with enhanced enzyme-labeled goat anti-rabbit IgG at 37◦C for 1 h. IHC staining was performed using a Article Title: MYLK4 promotes colorectal cancer progression by regulating lipid metabolism reprogramming via targeting ferroptosis Article Snippet: Following a wash with PBS, the slides were blocked with 10% BSA (#V900933, Sigma-Aldrich) at 37°C for 1 h. The sections were then incubated overnight at 4°C with the specified primary antibodies. .. The following day, the sections underwent successive washes with PBS buffer for 5 min before being incubated with enhanced enzyme-labeled goat anti-rabbit IgG at 37°C for 1 h. IHC staining was performed using a Binding Assay:Article Title: A Wireless Endovascular Deep Brain Stimulator for Parkinson's Disease Article Snippet: Deep brain stimulation (DBS) is a well-established treatment for Parkinson’s disease (PD), yet its traditional approaches involving craniotomy and battery implants are highly invasive and pose significant clinical risks.. To overcome these limitations, we developed a novel wireless endovascular DBS system (WE-DBS) that enables minimally invasive, battery-free stimulation via a vascularly implanted stent electrode and ultrasound-powered wireless energy transmission.. In an MPTP-induced PD mouse model, WE-DBS treatment significantly enhanced motor performance and protected dopaminergic neurons in the substantia nigra. Blocking Assay:Article Title: A Wireless Endovascular Deep Brain Stimulator for Parkinson's Disease Article Snippet: Deep brain stimulation (DBS) is a well-established treatment for Parkinson’s disease (PD), yet its traditional approaches involving craniotomy and battery implants are highly invasive and pose significant clinical risks.. To overcome these limitations, we developed a novel wireless endovascular DBS system (WE-DBS) that enables minimally invasive, battery-free stimulation via a vascularly implanted stent electrode and ultrasound-powered wireless energy transmission.. In an MPTP-induced PD mouse model, WE-DBS treatment significantly enhanced motor performance and protected dopaminergic neurons in the substantia nigra. Immunolabeling:Article Title: A Wireless Endovascular Deep Brain Stimulator for Parkinson's Disease Article Snippet: Deep brain stimulation (DBS) is a well-established treatment for Parkinson’s disease (PD), yet its traditional approaches involving craniotomy and battery implants are highly invasive and pose significant clinical risks.. To overcome these limitations, we developed a novel wireless endovascular DBS system (WE-DBS) that enables minimally invasive, battery-free stimulation via a vascularly implanted stent electrode and ultrasound-powered wireless energy transmission.. In an MPTP-induced PD mouse model, WE-DBS treatment significantly enhanced motor performance and protected dopaminergic neurons in the substantia nigra. Light Microscopy:Article Title: A Wireless Endovascular Deep Brain Stimulator for Parkinson's Disease Article Snippet: Deep brain stimulation (DBS) is a well-established treatment for Parkinson’s disease (PD), yet its traditional approaches involving craniotomy and battery implants are highly invasive and pose significant clinical risks.. To overcome these limitations, we developed a novel wireless endovascular DBS system (WE-DBS) that enables minimally invasive, battery-free stimulation via a vascularly implanted stent electrode and ultrasound-powered wireless energy transmission.. In an MPTP-induced PD mouse model, WE-DBS treatment significantly enhanced motor performance and protected dopaminergic neurons in the substantia nigra. other:Article Title: Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multi-Selective Inhibitors in NRAS -Mutated Melanoma Article Snippet: Sections were rinsed with Tris-Buffered Saline with 0.1%(v/v) Tween 20 (TBST) before applying a 2.5%(v/v) normal horse serum blocking solution (# Microscopy:Article Title: FGF9 drives mitochondrial biogenesis in glioblastoma by activating the CREB-PGC-1α axis. Article Snippet: Background: Mitochondrial biogenesis is upregulated in glioblastoma to support tumor growth, invasion, and chemoresistance by meeting the heightened metabolic demands of cancer cells.. Fibroblast growth factor 9 (FGF9) is a potent oncogenic driver in various cancers, promoting proliferation, survival, and angiogenesis.. However, its role in regulating mitochondrial metabolism in glioblastoma remains unclear. |